A federal judge has refused to dismiss a trio of antitrust lawsuits against pharmaceuticals giant GlaxoSmithKline that accuse the company of using a series of illegal tactics to delay the approval of generic versions of Flonase, a popular allergy drug.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *